|
Directors
Jonathan Goldin M.D., Ph.D. - Founder and Chief Executive Officer
Dr. Goldin trained at the University of Cape Town Medical School obtaining his MbChb in 1983. He completed his post-doctorate (Ph.D.) in 1990. He then completed his postgraduate training in Diagnostic Radiology in 1994 at the St. Bartholomew’s Hospital in London, England and his fellowship in Thoracic Radiology at the University of California, Los Angeles.
Dr. Goldin is a Professor of Radiology at the David Geffen School of Medicine at UCLA. He is Chief of Radiology at the Santa Monica-UCLA Medical Center, Division Chief of the Multi-Specialty Division and Vice Clinical Chair in the Department of Radiology at the David Geffen School of Medicine. He is also a Director of both the Thoracic Imaging Research Laboratory and the Thoracic Imaging Fellowship Program.
Dr. Goldin’s clinical and research interests include use of imaging in the early detection of disease, including lung cancer and coronary calcification screening as well as the development of computer-aided systems for the detection, characterization and quantization of diffuse lung disease and cardiovascular diseases.
Matthew Brown Ph.D.- Founder and Chief Scientific Officer
After receiving his doctorate in Computer Science from the University of New South Wales in his native Australia, Dr. Matthew Brown joined the UCLA Department of Radiological Sciences in 1996 and is currently an Associate Professor.
Dr. Brown has more than 15 years of R&D experience in quantitative medical image analysis in medicine, computer vision, and computer-aided diagnosis systems applied to clinical trials. As a computer scientist he has more than 20 years experience in software engineering, database administration and system validation.
Dr. Brown's research interests include the development of quantitative imaging biomarkers. Measurements are made using automated computer vision systems to increase accuracy and reproducibility. Machine learning and classification techniques are used for prediction or early assessment of treatment outcomes.
|
